Citadel Advisors’s Clearside Biomedical CLSD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
Hold
0
5960
2025
Q1
Hold
0
6057
2024
Q4
Sell
-71,603
Closed -$90.9K 6078
2024
Q3
$90.9K Sell
71,603
-25,027
-26% -$31.8K ﹤0.01% 4961
2024
Q2
$126K Buy
96,630
+26,457
+38% +$34.4K ﹤0.01% 4862
2024
Q1
$107K Buy
70,173
+24,335
+53% +$37.2K ﹤0.01% 5050
2023
Q4
$53.6K Buy
45,838
+26,090
+132% +$30.5K ﹤0.01% 5092
2023
Q3
$17.2K Buy
19,748
+2,386
+14% +$2.08K ﹤0.01% 5337
2023
Q2
$19.4K Sell
17,362
-50,147
-74% -$56.2K ﹤0.01% 5257
2023
Q1
$70.2K Buy
67,509
+64,928
+2,516% +$67.5K ﹤0.01% 5051
2022
Q4
$2.89K Buy
+2,581
New +$2.89K ﹤0.01% 5851
2022
Q3
Sell
-15,266
Closed -$23K 5967
2022
Q2
$23K Sell
15,266
-15,873
-51% -$23.9K ﹤0.01% 5682
2022
Q1
$71K Sell
31,139
-7,543
-20% -$17.2K ﹤0.01% 5789
2021
Q4
$107K Sell
38,682
-199,996
-84% -$553K ﹤0.01% 5866
2021
Q3
$1.43M Buy
238,678
+200,025
+517% +$1.2M ﹤0.01% 3380
2021
Q2
$188K Buy
38,653
+13,728
+55% +$66.8K ﹤0.01% 5616
2021
Q1
$62K Buy
+24,925
New +$62K ﹤0.01% 6036
2020
Q4
Hold
0
5110
2020
Q3
Sell
-133,086
Closed -$250K 4729
2020
Q2
$250K Buy
133,086
+67,229
+102% +$126K ﹤0.01% 3932
2020
Q1
$112K Buy
65,857
+8,270
+14% +$14.1K ﹤0.01% 4317
2019
Q4
$167K Buy
+57,587
New +$167K ﹤0.01% 4178
2019
Q3
Sell
-54,211
Closed -$53K 4711
2019
Q2
$53K Buy
54,211
+4,091
+8% +$4K ﹤0.01% 4346
2019
Q1
$69K Sell
50,120
-13,897
-22% -$19.1K ﹤0.01% 4163
2018
Q4
$68K Buy
64,017
+37,558
+142% +$39.9K ﹤0.01% 4073
2018
Q3
$163K Sell
26,459
-46,922
-64% -$289K ﹤0.01% 3807
2018
Q2
$784K Sell
73,381
-104,819
-59% -$1.12M ﹤0.01% 2841
2018
Q1
$1.91M Buy
+178,200
New +$1.91M ﹤0.01% 1977
2017
Q3
Sell
-12,881
Closed -$117K 3708
2017
Q2
$117K Buy
+12,881
New +$117K ﹤0.01% 3275